Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 1, 2003

Stroke. 2003
Published online before print May 1, 2003, doi: 10.1161/01.STR.0000071526.45277.44
A more recent version of this article appeared on June 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/6/1389    most recent
01.STR.0000071526.45277.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tseng, M.-Y.
Right arrow Articles by Kirkpatrick, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tseng, M.-Y.
Right arrow Articles by Kirkpatrick, P. J.
Related Collections
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

Submitted on December 15, 2002
Accepted on December 18, 2002

Effect of Hypertonic Saline on Cerebral Blood Flow in Poor-Grade Patients With Subarachnoid Hemorrhage

Ming-Yuan Tseng MD, MPhil; Pippa G. Al-Rawi BSc; John D. Pickard FRCS, MChir; Frank A. Rasulo MD; and Peter J. Kirkpatrick FRCS (SN)*

From the Academic Department of Neurosurgery, Neurosciences Care Unit (F.A.R.), Addenbrooke's Hospital, Cambridge, UK.

* To whom correspondence should be addressed. E-mail: pjk21{at}medschl.cam.ac.uk.

Background and Purpose--The goal of this study was to examine the effects of hypertonic saline on cerebral blood flow (CBF) in poor-grade patients with subarachnoid hemorrhage.

Methods--We administered 23.5% hypertonic saline (2 mL/kg IV) 1 time to 10 patients, 2 times to 7 patients, and 3 times to 1 patient. All patients had transcranial Doppler (TCD), intracranial pressure (ICP) monitoring, and analysis of serum sodium and osmolality; 6 had xenon CT (XeCT). Data were used to characterize the changes in CBF, cerebral vascular resistance (CVR), ICP, cerebral perfusion pressure (CPP), and potential rheological mechanisms of action.

Results--In the first treatment episode, CPP increased 26.8% (P=0.0003, at 28.3 minutes) from a rise in mean arterial blood pressure (ABP) of 10.5% (P=0.02, at 22.2 minutes) and a fall in ICP (-74.7%, P=0.002, at 60.0 minutes). Flow velocity (FV) of the middle cerebral artery increased 70.8% (P=0.00005, at 20.0 minutes), resulting in a corresponding fall in estimated CVR (-26.6%, P=0.01, at 16.3 minutes). The half-lives of effects on ABP, CPP, ICP, FV, and estimated CVR were 20.0, 53.6, 139.1, 42.7, and 27.1 minutes, respectively. In the second treatment episode, all these parameters had the same response except estimated CVR, which did not reach statistical significance. XeCT confirmed the increase in CBF (22.9%, P=0.02) without regional differences. A fall in CBF after hypertonic saline was identified in only a single region of interest in a patient in whom baseline flow was low but not infarcted. Serum sodium rose by 11.4 and 8.8 mmol/L, and osmolality rose by 26.7 and 16.3 mosm/L in the first and second treatment episodes, respectively. Hemoglobin decreased by 0.7 and 0.6 g/L and hematocrit decreased by 1.9% and 2.4% in the first and second treatment episodes, respectively.

Conclusions--We found that 23.5% hypertonic saline increases CBF in poor-grade patients with subarachnoid hemorrhage. These effects are associated with improved indexes of blood rheology. Potential therapeutic benefits are discussed.


Key words: cerebral blood flow • computed tomography • saline solution, hypertonic • subarachnoid hemorrhage • xenon




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Oddo, J M Levine, S Frangos, E Carrera, E Maloney-Wilensky, J L Pascual, W A Kofke, S A Mayer, and P D LeRoux
Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension
J. Neurol. Neurosurg. Psychiatry, August 1, 2009; 80(8): 916 - 920.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
R. S. Darwish, E. Ahn, and N. S. Amiridze
Role of Transcranial Doppler in Optimizing Treatment of Cerebral Vasospasm in Subarachnoid Hemorrhage
J Intensive Care Med, July 1, 2008; 23(4): 263 - 267.
[Abstract] [PDF]


Home page
Br J AnaesthHome page
J. P. Coles
Imaging after brain injury
Br. J. Anaesth., July 1, 2007; 99(1): 49 - 60.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Kaakinen, H. Alaoja, J. Heikkinen, S. Dahlbacka, P. Laurila, K. Kiviluoma, T. Salomaki, H. Tuominen, P. Ohtonen, F. Biancari, et al.
Hypertonic Saline Dextran Improves Outcome After Hypothermic Circulatory Arrest: A Study in a Surviving Porcine Model
Ann. Thorac. Surg., January 1, 2006; 81(1): 183 - 190.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Hypertonic Saline for Poor-Grade SAH
Journal Watch Neurology, August 8, 2003; 2003(808): 2 - 2.
[Full Text]


Home page
StrokeHome page
J. I. Suarez
Editorial Comment: Salting the Brain to Improve CBF in SAH Patients
Stroke, June 1, 2003; 34(6): 1396 - 1397.
[Full Text] [PDF]